Blog

»  Posts By   March 2017 

Frier Levitt Attorneys Selected to the 2017 New Jersey Super Lawyers and 2017 Super Lawyers Rising Stars Lists

Frier Levitt is pleased to announce that four of the firm’s attorneys have been selected to the 2017 New Jersey Super Lawyers list and 2017 New Jersey Super Lawyers Rising Stars list. Co-Founding Partner Jonathan E. Levitt, Esq., was selected to his 12th straight overall New Jersey Super Lawyers list, having been selected to the New Jersey Super Lawyers since 2011 and previously to the New Jersey Super Lawyers Rising...

Qui Tam Case Against Physicians and Hospital Advances on What May Have Been a Technical Oversight

A U.S. District Judge found that two agreements between a set of doctors and a University of Pittsburgh Medical Center-owned hospital ran afoul of the Stark Law and the False Claims Act, the former of which prohibits a physician from referring Medicare patients for designated health services to an entity with which the physician (or immediate family member) has a financial relationship, and the latter of which prohibits the filing of...

White Paper: “Performance” Based DIR Fees: A Rigged System with Disparate Effect on Specialty Pharmacies, Medicare Part D Beneficiaries and the U.S. Healthcare System

In this White Paper, the National Association of Specialty Pharmacy (NASP) and Frier Levitt explore the disparate impact that certain Pharmacy Benefit Managers (PBMs) "Direct and Indirect Remuneration" fees (commonly known as "DIR Fees") have on specialty pharmacies, Medicare beneficiaries and the healthcare system at large. It examines how some PBM-imposed DIR Fees, often calculated on a percentage of the total cost of the medication, have had a disparate impact...

DiGuglielmo Joins Frier Levitt as Counsel

Frier Levitt, LLC, a national boutique healthcare law firm, announced today that Theresa M. DiGuglielmo, Esq., has joined the firm as Counsel. Theresa rejoins the firm, having previously been an Associate in the firm’s Healthcare Department for ten years. Her Practice will focus primarily on regulatory and transactional matters. As a healthcare attorney, Theresa has enjoyed a varied practice and developed special areas of interest in medical supergroups, analyzing business...

The 21st Century Cures Act: Its Impact on Home Infusion and How Providers Can Respond

    When the 21st Century Cures Act was signed into law on December 13, 2016, home infusion providers began wondering how they would survive the changes in the reimbursement pricing model. With reimbursements now based on Average Sales Prices (ASP), rather than Average Wholesale Price (AWP), providers want to know how their revenue will be impacted and if servicing infusion patients will continue to be feasible. Join John E....
12